The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 18, 2012
Filed:
Jun. 03, 2009
Christian Harcken, New Milford, CT (US);
Rajashekhar Betageri, Bethel, CT (US);
Todd Bosanac, New Milford, CT (US);
Michael Jason Burke, Chesire, CT (US);
Soojin Kim, Demarest, NJ (US);
Daniel Kuzmich, Danbury, CT (US);
Thomas Wai-ho Lee, Brookfield, CT (US);
Zhibin LI, Berlin, CT (US);
Pingrong Liu, Southbury, CT (US);
John Lord, Poughkeepsie, NY (US);
Hossein Razavi, Danbury, CT (US);
Jonathan Timothy Reeves, New Milford, CT (US);
David Thomson, Ridgefield, CT (US);
Christian Harcken, New Milford, CT (US);
Rajashekhar Betageri, Bethel, CT (US);
Todd Bosanac, New Milford, CT (US);
Michael Jason Burke, Chesire, CT (US);
Soojin Kim, Demarest, NJ (US);
Daniel Kuzmich, Danbury, CT (US);
Thomas Wai-ho Lee, Brookfield, CT (US);
Zhibin Li, Berlin, CT (US);
Pingrong Liu, Southbury, CT (US);
John Lord, Poughkeepsie, NY (US);
Hossein Razavi, Danbury, CT (US);
Jonathan Timothy Reeves, New Milford, CT (US);
David Thomson, Ridgefield, CT (US);
Boehringer Ingelheim International GmbH, Ingelheim am Rhein, DE;
Abstract
Compounds of Formula (I) wherein R, R, X, and Y are as defined herein, or a tautomer, optical isomer, prodrug, co-crystal, or salt thereof; pharmaceutical compositions containing such compounds, and methods of modulating the glucocorticoid receptor function and methods of treating disease-states or conditions mediated by the glucocorticoid receptor function or characterized by inflammatory, allergic, or proliferative processes in a patient using these compounds.